Studies pinpoint the workings of a targeted treatment approach for multiple sclerosis.

Published Date: 29 May 2024

Paul M. Lieberman, Ph.D. of the Wistar Institute. D. and a lab group under the direction of Samantha Soldan, Ph.D., senior staff scientist and first author. C. have elucidated the potential contribution of B cells harboring Epstein-Barr virus (EBV).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

4.

Charles III, King of Kings, is Cancerous.

5.

The Truth About Apple AirPods


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot